Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A while back, I heard a rumor that DL was trying to sell MMP licenses at deep

All the Creditors only have a set amount of debt, when that is satisfied, they go away.

What this means is that in many ways they and PTSC have competing interests. Their input to the TPL Reorganization plan and short term interest of receiving repayment cash flow as quickly as possible inordinately impacts PTSC Shareholder's interests in achieving the level of necessary licensing revenues which will move the needle on our stock price.

I wrote about this early on, because I saw no Motions or Filing or legal Arguments by PTSC asking the court to grant us additional consideration (due to our Co-Owership of this TPL asset, and us being a public company with only this one revenue producer) counterweight to the stacked Creditor's Committee, because PTSC is only a very very minor creditor in that Committee.

Share
New Message
Please login to post a reply